Risk Assessment

13 Resources

Knowledge Center


The National Lipid Association is your destination for the science of lipid medicine. Now, everything we know is in one place.

Risk Assessment

13 Available Resources

Articles 6
Infographics 0
Podcasts 0
Videos & Webinars 7
Videos & Webinars

The Lipid Panel – Inflammatory Diseases

Videos & Webinars

The Lipid Panel – Diabetes and ASCVD Risk

Videos & Webinars

Lowering ASCVD Events by Treating Residual Inflammatory Risk – Discussion of Low Dose Colchicine

Videos & Webinars

Cutting Edges in the Lipid World

Videos & Webinars

Cardiovascular Imaging Use to Assess Risk

Videos & Webinars

Lp(a) & CVD: Is it Time for Universal Screening?

Videos & Webinars

Pregnancy-Lipid Effect & ASCVD Risk Management

Articles

A Personalized Approach to Risk Stratification

Clinical practice guidelines are integral to daily management of cardiovascular diseases, including hyperlipidemia. The most 2018 Multisociety Cholesterol Guidelines advocate…

Articles

Risk Assessment Tools and Dietary Questionnaires

Risk assessment tools and lifestyle surveys can play a major role in screening patients for risk of atherosclerotic cardiovascular disease…

Articles

Understanding Differences in ASCVD Risk and Outcomes in South Asians

A greater prevalence of dyslipidemia, insulin resistance, and atherosclerotic cardiovascular disease (ASCVD) and related-mortality are now well-recognized in South Asians…

Articles

Statins for Primary Prevention in Women: How an Individual-Benefit Model Could Expand Treatment to Hypercholesterolemic Women Under Age 65 with 10-Year ASCVD Risk Less Than 7.5%

Evidence in support of statins for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in women was sparse until recently.1 …

Articles

Evaluation of Women for the Primary Prevention of Atherosclerotic Cardiovascular Disease

The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic…

Articles

Targeting Atherogenic Cholesterol Goals for Patients that Meet the Criteria of ‘Extreme’ ASCVD Risk

The Very High ASCVD Risk Category Atherosclerotic cardiovascular disease (ASCVD) risk assessment has long been simplified to only several major…

Become A Member

When you become a member of the NLA, you become part of a collegial multidisciplinary group of leaders dedicated to improving lipid and cardiometabolic health.

Speaker at NLA Conference